Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
NCT03204032Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in extra-pancreatic neuroendocrine tumor, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
thalidomide
03
Conditions
extra-pancreatic neuroendocrine tumor
Beyond the preview
Go deeper on NCT03204032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204032.